Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism.
Priapism secondary to sickle cell anemia has been treated with a variety of therapeutic regimens. Recurrent sickle cell priapism is common and in many cases results when detumescence has not been achieved reliably. We report on a patient with sickle cell disease and recurrent priapism who was treated successfully for more than a year with monthly gonadotropin-releasing hormone analogue therapy after failure of standard medical management.
Levine
L A
LA
Department of Urology, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois.
Guss
S P
SP
D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008297:Male; D011317:Priapism / Q000188:drug therapy* / Q000209:etiology; D012008:Recurrence
D016729:Leuprolide